Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

HTTPS

Secure .gov websites use HTTPS
A lock (LockA locked padlock) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Freedom 250 banner logo Join HHS in Celebrating Freedom 250
    • About HHS

      HHS is a U.S. executive department that touches the lives of nearly all Americans by protecting your rights, research, food safety, health care, aging, and much more.

      Explore About HHS
    • About the Department
      • Leadership
      • HHS Divisions
      • Organizational Chart
      • Priorities
      • Budget in Brief
      • Contact Us
    • Press Room
      • Press Releases
      • Request for Comment
      • Request for Interview
      • Connect on Social Media
      • HHS Live
      • Podcasts
    • Careers
      • Working at HHS
      • Opportunities for Attorneys
      • Join the Health Workforce
      • I am HHS
      • New Employee Orientation
      • Transportation Services
    • Standards and Compliance
      • Gold Standard Science
      • Accessibility
      • Plain Writing
      • Digital Communications Standards
      • Records Management
    • Accountability and Transparency
      • Freedom of Information Act (FOIA)
      • Open Government
      • No Fear Act
      • Privacy at HHS
  • RealFood.gov
  • MAHA
    • Programs & Services

      HHS is responsible for public health, health care, and human/social services for the United States of America. This includes administering over 100 programs and services.

      Explore Programs & Services
    • Health Care
      • Find a Health Center
      • Find an Indian Health Service Facility
      • Find Support for Mental Health, Drugs, or Alcohol
      • Find a Cancer Center
      • Dental Care Options
      • Telehealth
    • Health Insurance
      • Medicare – 65+ or With Disability
      • Medicaid - Low-Income, With Disability, or Pregnant
      • Children’s Health Insurance Programs (CHIP)
      • Find Health Insurance Coverage
      • Insurance Help for Mental Health and Substance Use
      • No Surprise Medicals Bills
    • Social Services
      • Programs for Children and Families
      • Programs for People with Disabilities
      • Programs for Older Adults
      • Resources for Caregivers
    • Public Health and Prevention
      • Emergency Preparedness and Response
      • Healthy Lifestyle
      • Mental Health and Substance Use
      • Food Safety and Nutrition
      • Drug and Product Safety
    • Health Research and Information
      • National Library of Medicine
      • Surgeon General Reports
      • Health Data
      • National Center for Health Statistics
      • Medline Plus
      • Clinical Research Studies
      • Volunteering to Participate in Research
    • Laws & Regulations

      HHS protects and helps you understand the laws and regulations, also known as "rules," that govern the nation. You also have the power to voice your opinion on these laws and regulations.

      Explore Laws & Regulations
    • Regulatory Information
      • What is a Rule?
      • Find Rules by Division
      • Comment on Open Rules
      • Suggest Deregulatory Actions
      • Understand Key Federal Laws
    • Civil Rights
      • Your Civil Rights
      • Civil Rights Laws Enforced by HHS
      • Health Information Privacy
      • Substance Use Disorder Patient Confidentiality
      • Conscience and Religious Freedom
    • Laws and Regulations by Topic
      • HIPAA Privacy Rule
      • Health Insurance Protections
      • Health IT Legislation
      • Food and Drug Safety
      • Public Health Emergencies
    • Human Research Protections
      • The Belmont Report
      • Regulations, Policy, and Guidance
      • Human Subjects Regulations (45 CFR 46)
      • Register IRBs and Obtain FWAs
      • Trainings, Tutorials, and Workshops
      • International Research
    • Complaints and Appeals
      • File a Medicare Complaint
      • File a HIPAA Complaint
      • File a Civil Rights Complaint
      • Appeal an Insurance Company Decision
      • Report Fraud, Waste, and Abuse to OIG
      • Report a Problem to the FDA
      • Report a Tip on the Chemical and Surgical Mutilation of Children
    • Grants & Contracts

      HHS gives the most money in grants of any federal agency in the U.S. Find out about our grants and how your organization can apply for them. We also provide information on how you can work with us and our support of small businesses.

      Explore Grants & Contracts
    • Grants
      • Get Ready for Grants Management
      • Grant Policies and Regulations
      • Research Grants and Funding from NIH
      • Search Grants.gov
      • Avoid Grant Scams
      • Contact HHS Grant Officials
    • Contracts
      • Get Ready to Do Business with HHS
      • Programs for Businesses
      • Contract Policies and Regulations
      • Search Opportunities on SAM.gov
      • Contact HHS Contracting Managers
    • Small Business
      • Contract Opportunities
      • Small Business Programs
      • Small Business Resources
      • Contact Small Business Staff
    • Radical Transparency

      HHS protects and helps you understand the laws and regulations, also known as "rules," that govern the nation. You also have the power to voice your opinion on these laws and regulations.

      Explore Radical Transparency
    • CDC’s ACIP Conflicts of Interest
    • Ending Anti-Semitism on College Campuses
    • Ending Wasteful Spending
    • Keeping Food Ingredients Safe
    • Chemical Contaminants Transparency Tool
Breadcrumb
  1. Home
  2. About HHS
  3. Agencies
  4. DAB
  5. Decisions
  6. ALJ Decision…
  7. 2026 ALJ Decisions
  8. In re LCD Complaint: Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (NAATS) (L38229), DAB, CR6894 (2026)
  • Departmental Appeals Board (DAB)
  • About DAB
    • Organizational Overview
    • Who are the Judges?
    • DAB Divisions
    • Contact DAB
  • Filing an Appeal Online
    • DAB E-File
    • Medicare Operations Division (MOD) E-File
  • Different Appeals at DAB
    • Appeals to DAB Administrative Law Judges (ALJs)
      • Forms
      • Procedures
    • Appeals to Board
      • Practice Manual
      • Guidelines
      • Regulations
      • National Coverage Determination Complaints
    • Appeals to the Medicare Appeals Council (Council)
      • Forms
      • Fully Integrated Duals Advantage (FIDA) Demonstration Project
  • Alternative Dispute Resolution Services
    • Mediation
    • ADR Training
    • Other ADR Services
  • DAB Decisions
    • Board Decisions
    • DAB Administrative Law Judge (ALJ) Decisions
    • Medicare Appeals Council (Council) Decisions
  • Stakeholder Feedback
  • Careers
    • Open Career Opportunities
    • Internships & Externships

In re LCD Complaint: Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (NAATS) (L38229), DAB, CR6894 (2026)


Department of Health and Human Services
DEPARTMENTAL APPEALS BOARD
Civil Remedies Division

In re Local Coverage Determination (LCD) Complaint: Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (NAATS) (L38229)

Docket No. C-26-432
Decision No. CR6894
May 13, 2026

DECISION DISMISSING COMPLAINT FOR WANT OF JURISDICTION AND UNACCEPTABILITY

I. Introduction

On March 13, 2026,1  the Civil Remedies Division received a Medicare Redetermination Request Form filed by Medicare beneficiary S.M.2  DAB E-file Dkt. No. C-26-432, Doc. No. 1 (Putative Complaint).  That form is used to seek redetermination after a first-level denial of a Medicare claim by a contractor for the Centers for Medicare & Medicaid Services (CMS). 

With the redetermination request, S.M. attached an October 30, 2025 notice from CMS contractor Novitas Solutions explaining it had denied coverage for payment by the Medicare program for a nucleic acid detection test identified under CPT code 87507.  DAB E-file Dkt. No. C-26-432, Doc. No. 1a (Denial Notice) at 4.  The contractor cited a denial code indicating it had denied S.M.’s claim applying a Local Coverage Determination (LCD) policy identified as L38229 and entitled Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (NAATS).  Id. 

Because Novitas applied an LCD policy to deny S.M.’s claim, and because challenges to the validity of LCD policies are heard in the Civil Remedies Division, my office interpreted S.M’s filing as a challenge to the validity of L38229, resulting in my designation to hear and decide this case as an LCD challenge.  42 C.F.R. § 426.410(b). 

Page 2

When a party files a challenge to the validity of an LCD policy, referred to as a complaint, I must first determine whether that complaint is acceptable, meaning it includes all the elements required by the applicable regulations to be permitted to proceed.  Doing so, I determined S.M. had not provided sufficient evidence to assess the timeliness of his complaint and failed to provide several other required elements. 

I therefore issued an Acknowledgment of Receipt and Order to Amend Unacceptable Complaint (Order to Amend) on March 20, 2026.  In that order, I informed S.M. that I had no jurisdiction over the denial of individual claims by Medicare beneficiaries but instead could only hear challenges to the validity of an LCD policy or provisions thereof.  Order to Amend at 2.  But to preserve S.M.’s hearing right if he wished to proceed, I treated his filing as an LCD challenge and advised him of the deficiencies that made his initial complaint unacceptable as an LCD challenge.  Id. at 4-5.  I also provided him with one opportunity to submit an acceptable complaint.  Id. at 5. 

I explained S.M.’s initial attempt to file a valid complaint failed because:  

(1) he did not provide documentation from a treating physician establishing the medical necessity for the service for which Novitas denied coverage;

(2) he did not provide evidence to support his claim that he did not receive the contractor’s October 30, 2025 notice until March 3, 2026;

(3) he failed to identify the LCD he wished to challenge or the specific provision(s) of the LCD adversely affecting him;

(4) he did not submit a statement explaining why the LCD provision he is challenging is not valid under the reasonableness standard; and

(5) he did not provide copies of clinical or scientific evidence in support of his complaint or explain why he believes such evidence shows the LCD is not reasonable.

Id. at 4-5.  

I directed S.M. to file an amended complaint correcting these deficiencies by April 20, 2026.  Id. at 5.  I advised S.M. that if he did not submit an acceptable amended complaint by that date, I would issue a decision dismissing this action.  Id.; 42 C.F.R. § 426.410(c)(2).  S.M. timely responded to my Order to Amend (Resp.) and submitted documents in support of his challenge.  DAB E-File Dkt. No. C-26-432, Doc. Nos. 3-3a.

Page 3

II. Discussion

A. I have no jurisdiction in this matter because S.M. does not challenge the validity of an LCD policy or provision.

S M. makes plain that he wishes to challenge Novitas’s application of L38229 to reject his claim.  Resp. at 1; DAB E-File Dkt. No. C-26-432, Doc. No. 3a at 70-91 (coverage guidance in support of S.M.’s application argument).  He explains at length how he met all the requirements imposed by the LCD policy and argues that properly applying L38229, Novitas should have approved his claim for coverage.  Resp. at 1-3. 

Nowhere in his response does S.M. challenge the validity of the LCD or its provisions.  He instead seeks review of whether Novitas properly applied L38229 to deny coverage for his claim by the Medicare program.  I have no jurisdiction over that issue.  See 42 C.F.R. § 426.325(b)(11).  Judges in the Civil Remedies Division only hear challenges to the validity of LCD policies, not the application of those policies to individual claims.3   See 42 C.F.R. §§ 426.110, 426.300. 

B. S.M. has not provided the necessary elements for a valid complaint to challenge an LCD provision.

Even if I were to construe S.M.’s request for hearing as a challenge to the validity of L38229, S.M. has failed to file an adequate complaint.  42 C.F.R. § 426.405(c)(2).  S.M.’s initial filing did not establish he was an aggrieved party or include documentation from the treating physician establishing the medical necessity of the test at issue.  42 C.F.R. § 426.410.  It also omitted three necessary elements for a valid complaint, namely evidence of timeliness, an Aggrieved Party statement, and clinical or scientific evidence with an explanation how that evidence demonstrates the LCD is not reasonable.  42 C.F.R. § 426.400(c)(3),(5),(6)(i). 

I provided S.M. an opportunity to correct these deficiencies.  However, S.M. corrected only two of the four deficiencies I identified in my Order to Amend; he failed to provide evidence to support his claim that he did not receive the contractor’s October 30, 2025 notice until March 3, 2026 and did not provide copies of clinical or scientific evidence in support of his complaint.  See Resp.  I recognize S.M.’s good-faith effort to amend his

Page 4

complaint.  But for these reasons, I must find that for the purpose of challenging the validity of an LCD, S.M.’s complaint is unacceptable. 

C. S.M. may wish to refile his appeal in the proper venue.

As I have explained, S.M.’s amended filing shows he intended to appeal the denial of his individual claim for coverage by the Medicare program.  He does not wish to challenge the validity of the LCD used to deny his claim; he wishes to argue Novitas improperly applied the LCD to do so.  After Novitas denied his claim at the initial level, S.M. should have requested redetermination by Novitas.  See 42 C.F.R. § 405.940.  His initial filing in this case – a Medicare Redetermination Request – is the correct form to make that request.  See Putative Complaint.  But S.M. filed it in the wrong place.  Notivas’s denial notice plainly instructs a redetermination request should be sent to:

Medicare Claims Office
c/o Novitas Solutions
P.O. Box 3413
Mechanicsburg, PA 17055-1852

Denial Notice at 7. 

I note that S.M. appears to be a lawyer.  Putative Complaint at 2.  It is unclear to me why he opted to file his redetermination request as an appeal in the Civil Remedies Division.  See 42 C.F.R. § 405.944(a) (“The request for redetermination must be filed with the contractor indicated on the notice of initial determination.”).  Still, S.M. may wish to pursue appeal of the initial denial of his claim by following the instructions at page 7 of the Denial Notice.  If S.G. does so, his appeal will be untimely.  However, Novitas may accept his untimely appeal if he can show good cause for missing the deadline.  The Secretary’s regulations identify circumstances a contractor may consider to establish good cause, among them, “The party sent the request to a Government agency in good faith within the time limit, and the request did not reach the appropriate contractor until after the time period to file a request expired.”  42 C.F.R. § 405.942(b)(3).  S.M.’s improper filing in the Civil Remedies Division appears to provide a basis for a good cause finding. 

However, if S.G. wishes to pursue appeal of his claim denial, he should file his redetermination request with Novitas immediately.  He must include an explanation for his untimely filing and show good cause for both the untimely filing in the Civil Remedies Division and in sending his request to Novitas.  S.G. may wish to consider attaching this dismissal order to establish the date he filed his appeal in the Civil Remedies Division and to explain his delay in filing arose in part because his redetermination request was interpreted by my office as an LCD challenge and treated as such. 

Page 5

III. Conclusion

S.M. seeks to challenge Novitas’s individual claim determination, an issue over which I do not have jurisdiction.  Even if I construed his appeal as a challenge to the validity of the LCD policy Novitas applied to deny his claim, S.M. did not establish he timely filed his complaint, provide copies of scientific or clinical evidence to support his complaint, or articulate how such evidence shows L38229, the LCD at issue here, is unreasonable. 

S.M.’s complaint is unacceptable under 42 C.F.R. § 426.410(b)(2).  I am thus required to dismiss it.  42 C.F.R. § 426.410(c)(2).  S.M. may not file another complaint seeking review of the same LCD policy for six months.  42 C.F.R. § 426.410(c)(3).  He has 30 days from the date of this decision to file an appeal with the Departmental Appeals Board.  42 C.F.R. § 426.465.  

/s/

Bill Thomas Administrative Law Judge

  • 1

    S.M.’s complaint is postmarked March 5, 2026.  For purposes of this decision, I deem that date to be the date of filing.

  • 2

    I refer to the beneficiary by his initials to protect his privacy.  See 68 Fed. Reg. 63,691, 63,708, 63,711 (Nov. 7, 2003).

  • 3

    Even if S.M. had filed his appeal before a judge with jurisdiction over individual claim denials, housed in the Office of Medicare Hearings and Appeals, his claim still would have been dismissed because he did not first seek redetermination and then reconsideration.  See 42 C.F.R. §§ 405.940 (affording the right to redetermination after a contractor’s initial denial), 405.960 (affording the right to reconsideration by a different independent contractor if a party is dissatisfied with the first contractor’s redetermination), 1000(a) (permitting appeal to an administrative law judge where a party is dissatisfied with the reconsidered determination).

Back to top
Secretary Robert F. Kennedy Jr.

Follow @SecKennedy

HHS icon

Follow @HHSGov

HHS Email updates

Receive email updates from HHS.

Subscribe

HHS Logo

HHS Headquarters

200 Independence Avenue, S.W.
Washington, D.C. 20201
Toll Free Call Center: 1-877-696-6775​

  • Contact HHS
  • Careers
  • HHS FAQs
  • Nondiscrimination Notice
  • Press Room
  • HHS Archive
  • Accessibility Statement
  • Budget/Performance
  • Inspector General
  • Web Site Disclaimers
  • EEO/No Fear Act
  • FOIA
  • The White House
  • USA.gov
  • Vulnerability Disclosure Policy